FOR OUTSIDE THE US AND CANADA ONLY

Infectious Disease

The first fully automated solution for Chlamydia trachomatis antibody detection

Chlamydia trachomatis IgG and IgA

Infectious Disease

Chlamydia trachomatis is one the most common cause of sexually transmitted diseases worldwide. Chlamydial infection is asymptomatic in most women and many men: left untreated, it leads to sequelae that place heavy medical, psychosocial, and economic burdens on women, men, infants and the healthcare system. As infections are either asymptomatic, laboratory techniques are the sole means of diagnosing acute infections. DiaSorin LIAISON® serology line has been developed to influence patient management and to make quick and rapid diagnosis of Chlamydia trachomatis infection.

The detection of specific IgA antibodies is indicative of active Chlamydial infection and has been shown to be an important marker because of the shorter lifetime of IgA antibodies which persist only as long as antigenic stimulation exists. IgA antibody detection is, moreover, suitable for post-therapy follow-up. IgG antibody detection is a marker for a Chlamydia-positive immune-response, either for current, chronic or past infections. For a reliable interpretation of results both IgG and IgA antibodies must be tested.

Main Features of C. trachomatis assays • Number of tests: 100 • Antigen: 4 biotynilated peptides• Label: Isoluminol derivative• Method: CLIA• Assay format: semi-quantitative IgG assay, qualitative IgA assay• Sample type: Serum/Plasma

Flexibility enables quick and accurate results• High throughput• Reagent stability on board: 8 weeks• Two-point calibration for IgA and IgG assays stable for 8 weeks• Sample volume: 20 μL

Ordering informationLIAISON® Chlamydia trachomatis IgG (code 310570)LIAISON® Chlamydia trachomatis IgA (code 310580)

LIAISON® control Chlamydia trachomatis IgG (code 310571)LIAISON® control Chlamydia trachomatis IgA (code 310581)

The unique technological advantages of the LIAISON® systems, the quality of the reagents and antigen selection have been combined to create a new approach to the Chlamydia trachomatis diagnosis.

M08

7000

4284

/C 0

2/19

Product availability subject to required regulatory approval

AVAILABLE ON SYSTEMS

Chlamydia trachomatis IgG and IgA

Indirect assays format Interpretation of results

IgG

IgA

IgG results IgA results Interpretation of results

Negative Negative No evidence of infection.

Positive Negative May indicate past infection.

Positive PositiveMay indicate acute or chronic infection.

Negative PositiveMay indicate acute or reactivation.

4 biotynilated peptides

IgG anti-humanIgG conjugate

4 biotynilated peptides

IgG anti-humanIgA conjugate

DiaSorin S.p.A.Via Crescentino

13040 Saluggia (VC) - ItalyTel. +39.0161.487526Fax: +39.0161.487670

www.diasorin.comE-mail: info@diasorin.it